Abstract
This case report is about reversible cardiomyopathy associated with intrathecal baclofen withdrawal. Previous literature has reported that enteral baclofen does not adequately control intrathecal baclofen withdrawal. In our case, coronary atherosclerosis did not play a role in the development of the cardiomyopathy. However, reinstitution of intrathecal baclofen promptly resulted in improvement. One could hypothesize that myocardial stunning from sympathetic hyperactivity led to a similar cardiomyopathy reported with catecholamine excess or acute sympathomimetic poisoning.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Mohammed I, Hussain A. Intrathecal baclofen withdrawal syndrome—a life-threatening complication of baclofen pump: A case report.BMC Clin Pharmacol. 2004;4:6.
Wittstein IS, Thiemann DR, Lima JAC, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress.N Eng J Med. 2005;352:539–548.
Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine.JAMA. 1991;265:1152–1154.
Jacobs LJ. Reversible dilated cardiomyopathy induced by methamphetamine.Clin Cardiol. 1989;12:725–727.
Schifferdecker B, Kodali D, Hausner E, Aragam J. Adrenergic shock — An overlooked clinical entity?Cardiol Rev. 2005;13: 69–73.
Stewart MJ, Fraser DM, Boon N. Dilated cardiomyopathy associated with chronic overuse of an adrenaline inhaler.Br Heart J 1992;68:221–222.
Haft JI. Cardiovascular injury induced by sympathetic catecholamines.Prog Cardiovasc Dis. 1975;17:73–86.
Carlsson C, Haggendal J. Arterial noradrenaline levels after ethanol withdrawal.Lancet. 1967;290:889.
Greenberg MI, Hendrickson RG. Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement.J Toxicol Clin Toxicol. 2003; 41:83–85.
Lacy CR, Contrada RJ, Robbins ML, Tannenbaum AK, Moreyra AE, Chelton S, Kostis JB. Coronary vasoconstriction induced by mental stress (simulated public speaking).Am J Cardiol. 1995;75:503–505.
Handforth CP. Isoproterenol-induced myocardial infarction in animals.Arch Pathol. 1962;73:161–165.
Singal PK, Yates JC, Beamish RE, Dhalla NS. Influence of reducing agents on adrenochrome-induced changes in the heart.Arch Pathol Lab Med. 1981;105:664–669.
Wheatley AM, Thandroyen FT, Opie LH. Catecholamine-induced myocardial cell damage: Catecholamines or adrenochrome.J Mol Cell Cardiol. 1985;17:349–359.
Fleckenstein A, Frey M, Fleckenstein-Grun G. Consequences of uncontrolled calcium entry and its prevention with calcium antagonists.Eur Heart J. 1983;4 suppl H:43–50.
Author information
Authors and Affiliations
Corresponding author
Additional information
There was no outside funding of any kind used for this study. Poster Presentation at the 2005 North American Congress of Clinical Toxicology Annual Meeting, Orlando, FL.
Rights and permissions
About this article
Cite this article
Pizon, A.F., LoVecchio, F. Reversible cardiomyopathy complicating intrathecal baclofen withdrawal: A case report. J. Med. Toxicol. 3, 187–189 (2007). https://doi.org/10.1007/BF03160938
Issue Date:
DOI: https://doi.org/10.1007/BF03160938